I already worked on one documentary. Any motorcycl
Post# of 148101
Let's see how the Leronlimab story plays out the next 6-12 months.
One issue, if we're talking about this seriously, is the story's optics or lack thereof. Like some other pharma stories, it's not super exciting to look at FDA meetings, drug trials, data, so there's likely a ceiling as a miniseries or MOW.